Order Now, Ships Today
$175.00
One-time
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Quality controlled from start to finish.
No outsourcing.
Tirzepatide is a synthetic peptide analog that has been investigated for its effects on insulin signaling, glucagon modulation, and gastric motility under experimental conditions. Tirzepatide is a GIP/GLP-1 works as a dual receptor agonist, meaning that it interacts with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which are involved in pathways related to metabolic regulation. Glucose-dependent insulinotropic polypeptide (GIP): Stimulates insulin release from the pancreas in response to food. Glucagon-like peptide-1 (GLP-1): Prompts insulin secretion and slows down gastric emptying.Preclinical research in animal models suggests that the combined effect of these two actions can lead to improved blood sugar control and weight loss. The enhanced metabolic regulation may carry the potential for improved cardiovascular function. This product requires reconstitution before use and is intended for research purposes only. Not for human consumption.